25 July 2017Catherine Lichten and Jon Sussex from RAND Europe share findings from work that explored the impact of research activity from the NIHR Oxford Biomedical Research Centre.
21 July 2017Duncan Young explores the need to develop new health research and efficient studies against the backdrop of public funding austerity, an ageing population and a productivity crisis in the pharmaceutical industry.
17 July 2017Clare Morgan explains how the NIHR is investing in research to improve the health and wealth of the nation. Her blog is the first in our #WeAreNIHR series.
10 July 2017In our latest blog, Peter Bull writes about how participating in a pedometer trial aiming to increase exercise among inactive and older adults has boosted his health and fitness.
05 July 2017Professor Jon Glasby writes the first in our series of blogs promoting the NIHR's new themed call on complex health and care needs in older people.
30 June 2017Professor Ajit Lalvani writes how the creation of a biobank has enabled the development of more efficient studies into developing tests for diagnosing tuberculosis.
26 June 2017Professor Tom Quinn continues our series of blogs for our I am Research campaign for International Clinical Trials Day. He writes about his journey from a cardiac nurse to becoming an academic spearheading award winning research.
Using my clinical training to drive my research ideas, and my research skills to change clinical practice
21 June 2017Anna Volkmer marks today's Chief Allied Health Professions Officer Annual Conference by writing about her research into finding speech and language interventions for dementia patients.
20 June 2017Jennifer McAnuff writes our latest blog ahead of tomorrow's Chief Allied Health Professions Officer Annual Conference. She highlights the importance of clinical academic training.
19 June 2017Helen Walters, Hannah Dorling and Tara Lamont write about the importance of frontline public health professionals getting involved in research, ahead of the Faculty of Public Health (FPH) Conference and Public Health Expo 2017.
15 June 2017We recently announced a phase 3 trial of simvastatin, a drug for people with secondary progressive MS. Now that the trial’s in setup Research Manager Marie Braisher lets us in on its inner workings.